-
1
المؤلفون: Anvi Khandelwal, Baanie Sawhney, John Cook, Emilie Scherrer, Shalini Bagga, Raquel Aguiar-Ibáñez, Dmitri Grebennik, Scott Soefje
المصدر: Journal for ImmunoTherapy of Cancer. 9:A941-A941
مصطلحات موضوعية: Pharmacology, Oncology, Cancer Research, medicine.medical_specialty, Schedule, business.industry, Melanoma, medicine.medical_treatment, Immunology, Pembrolizumab, medicine.disease, Internal medicine, Molecular Medicine, Immunology and Allergy, Medicine, Dosing, business, Adjuvant
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7af1f3e3202f213bbd013952090a7809Test
https://doi.org/10.1136/jitc-2021-sitc2021.897Test -
2
المؤلفون: Arielle G. Bensimon, Wei Gao, Madeline Jenkins, Emilie Scherrer, James Signorovitch, Raquel Aguiar-Ibáñez, Zheng-Yi Zhou, Clemens Krepler, Jingshu Wang, Yan Song
المصدر: Clinical Drug Investigation
مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, medicine.medical_treatment, Cost-Benefit Analysis, Population, Ipilimumab, Pembrolizumab, 030204 cardiovascular system & hematology, Placebo, Antibodies, Monoclonal, Humanized, 030226 pharmacology & pharmacy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Pharmacology (medical), Original Research Article, Adverse effect, education, Melanoma, Neoplasm Staging, Trametinib, education.field_of_study, business.industry, Dabrafenib, General Medicine, Health Care Costs, Middle Aged, Female, Quality-Adjusted Life Years, business, Adjuvant, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc665ba8e733bfe3fa1a444a1858bd33Test
https://pubmed.ncbi.nlm.nih.gov/32418051Test -
3
المؤلفون: Emilie Scherrer, Frank Xiaoqing Liu, Raquel Aguiar-Ibáñez, Maria Lorenzi, Stella Arndorfer, Clemens Krepler
المصدر: Journal of Drug Assessment
مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, Pembrolizumab, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Indirect Treatment, Internal medicine, melanoma, medicine, Adjuvant therapy, Stage III melanoma, business.industry, indirect treatment comparison, Melanoma, adjuvant therapy, Immunotherapy, medicine.disease, PD-1 inhibitor, Systematic review, immunotherapy, business, Adjuvant, 030217 neurology & neurosurgery
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f0bc61b33102d0182d0e731ab33821Test